Addleshaw Goddard supports the Margot Denoy Endowment Fund
Paris, 9 December 2025 – Addleshaw Goddard is committed to providing its legal expertise in support of the Margot Denoy Endowment Fund.
As part of its Pro Bono activities, Addleshaw Goddard Paris has formalised the signing of an engagement letter with the Margot Denoy Endowment Fund, becoming its unique legal partner for its legal matters.
Addleshaw Goddard places Pro Bono work at the heart of its professional and societal commitment. By mobilising the expertise of its teams to support non-profit organisations and mission-driven entities, the firm helps promote access to justice and contributes to initiatives with a proven social, cultural, or environmental impact.
This commitment is grounded in a long-term approach. Addleshaw Goddard prioritises partnerships built over time, based on listening, availability, and ongoing support for the projects it accompanies. This approach reflects the firm’s intention to actively contribute to positive collective dynamics and to provide rigorous, reliable legal assistance to organisations working for the public interest.
As the partner responsible for the Pro Bono at Addleshaw Goddard Paris, Charles Tissier (Partner, Finance) led and formalised this partnership.
About the Margot Denoy Endowment Fund
The Margot Denoy Endowment Fund was created in April 2025 by Ella Etienne-Denoy and Grégoire Denoy, in memory of Margot, their daughter and eldest child, who passed away on April 10 2024, before her third birthday.
The Fund is a public-interest organization whose mission is to increase funding to accelerate medical research on the most aggressive pediatric cancers, an area that remains largely underfunded. It mobilizes private resources in support of scientific innovation and the fight against these complex diseases.
The Fund stands out for its structured philanthropic approach and for implementing innovative value-sharing mechanisms with financial and economic stakeholders, making finance a sustainable lever for impact in support of research.
The Fund is also committed to raising awareness among the public and decision-makers, as well as bringing together a broad community of stakeholders (donors, scientists, families, and financial actors) around this cause.
